Background illustration for clinical trials search

Paid Clinical Trials Seattle

Discover 1,443 paid clinical trials in Seattle, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: Seattle WA, Victoria, Vancouver, Springfield OR,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase3, Recruiting

CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin

for
Sarcoma
Location: Seattle WA, Santa Monica CA, Pittsburgh PA,
Sponsor: CBA Research

Sex: All

Age: 18+

Code: NCT03002805

Phase1, Recruiting

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

for
AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia,
Location: Seattle WA, Denver CO, Gilbert AZ, Dallas TX, Tyler TX,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT04358393

Phase1, Phase2, Recruiting

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

for
Follicular Lymphoma, Marginal Zone Lymphoma
Location: Seattle WA, Rochester MN, Rochester NY, Boston MA
Sponsor: Enterome

Sex: All

Age: 18+

Code: NCT04669171

Phase1, Phase2, Recruiting

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

for
Mucositis, Nephrotoxicity, Ototoxicity
Location: Seattle WA, Merced CA, Santa Maria CA, La Jolla CA,
Sponsor: Matrix Biomed, Inc.

Sex: All

Age: 18+

Code: NCT03480971

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Seattle WA, Duarte CA, Orange CA, Irvine CA, Chicago IL,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT04590326

Phase1, Phase2, Recruiting

Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)

for
Leiomyosarcoma
Location: Seattle WA, Santa Monica CA, Phoenix AZ, Rochester MN,
Sponsor: Philogen S.p.A.

Sex: All

Age: 16 - 70+

Code: NCT03420014

Phase2, Recruiting
New

Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer

for
Locally Advanced Bladder Urothelial Carcinoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07667335

Phase1, Phase2, Recruiting
New

Uterine Lavage to Detect Ovarian Cancer Risk

for
BRCA Hereditary Ovarian Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: Female

Age: 18+

Code: NCT07772869

Recruiting
New

OM336 in Autoimmune Cytopenias

for
AIHA - Warm Autoimmune Hemolytic Anemia,
Location: Seattle WA, Duarte CA, Ann Arbor MI, Washington D.C. DC
Sponsor: Lakefront Biotherapeutics West LLC

Sex: All

Age: 18 - 70+

Code: NCT07083960

Phase1, Recruiting
New

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

for
Advanced Lung Non-Small Cell Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07322341

Phase2, Recruiting
New

A Home-Based Exercise Intervention (CAREFit-BMT) in Improving Heart Function Among Patients With High Risk Acute Myeloid Leukemia Undergoing Stem Cell Transplant

for
Acute Myeloid Leukemia
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07616921

Recruiting

Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma

for
Ann Arbor Stage II Follicular Lymphoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06442475

Phase2, Recruiting

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC

for
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer,
Location: Seattle WA, Milwaukee WI
Sponsor: Pancreatic Cancer Research Team

Sex: All

Age: 18+

Code: NCT03634332

Phase2, Recruiting

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer,
Location: Seattle WA, Salt Lake City UT, Santa Monica CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06586515

Phase1, Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

for
Non Small Cell Lung Cancer, Lung Cancer, Breast Cancer,
Location: Seattle WA, Beverly Hills CA, Duarte CA,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT05983432

Phase1, Recruiting

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

for
Neuroendocrine Tumors Unresectable,
Location: Seattle WA, Omaha NE, Rochester MN, Iowa City IA,
Sponsor: Perspective Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05636618

Phase1, Phase2, Recruiting

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostate Cancer
Location: Seattle WA, San Francisco CA, Murray UT, Duarte CA,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT04221542

Phase1, Recruiting

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

for
Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia,
Location: Seattle WA, Houston TX, Cincinnati OH, Nashville TN,
Sponsor: Vincerx Pharma, Inc.

Sex: All

Age: 18+

Code: NCT06034275

Phase1, Recruiting

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult, Metastatic Breast Cancer,
Location: Seattle WA, San Francisco CA, Los Angeles CA, Duarte CA,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06625775

Phase1, Recruiting

As one of the fastest growing cities in America, Seattle stands out as a pivotal location for clinical research. Home to an extensive healthcare network and prominent research institutions, Seattle offers innovative approaches to clinical research and a significant contribution to medical science.

Leading centers such as the Fred Hutchinson Cancer Research Center, the University of Washington Medical Center, and the Seattle Children's Research Institute are at the forefront of groundbreaking studies.

Why choose Seattle for clinical trials?

For those considering participating in a clinical trial, there are several reasons why Seattle is a prime choice. The city is home to a robust network of leading research institutions, which are known for their pioneering work and advanced medical research. Seattle’s collaborative environment and emphasis on innovation enhance the quality and impact of clinical studies.

By participating in a clinical trial in Seattle, you gain access to some of the most advanced research and treatments available, while also contributing to significant medical discoveries. The city's commitment to cutting-edge science and a supportive research infrastructure make it an ideal location for advancing medical knowledge and improving future healthcare outcomes.

Common conditions studied in Seattle

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Seattle